共 23 条
[1]
de Lawter DE, Moss JM, Tyroler S. Secondary failure of response to tolbutamide treatment, JAMA, 171, pp. 1786-1792, (1959)
[2]
Krall LP, Bradley RF., ‘Secondary failures' in the treatment of diabetes mellitus with tolbutamide and with phenformin, Diabetes, 11, pp. 88-91, (1962)
[3]
Shen SW, Bressler R., Clinical pharmacology of oral antidiabetic agents (II part), N Engl J Med, 296, pp. 787-793, (1977)
[4]
Schmeltz R., Wendorff HJ, Field JB., Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis‐resistant diabetics, J Clin Endocrinol Metab, 46, pp. 519-527, (1978)
[5]
Groop LC, Pelkonen R., Koskimies S., Bottazzo GF, Doniach D. Secondary failure to treatment with oral antidiabetic agents in non‐insulin‐dependent diabetes, Diabetes Care, 9, pp. 129-133, (1986)
[6]
Gutniak M., Karlander SG, Efendic S. Glyburide decreases insulin requirement, increases β‐cell response to mixed meal, and does not affect insulin sensitivity: effects of short and long‐term combined treatment in secondary failure to sulfonylurea, Diabetes Care, 10, pp. 545-554, (1987)
[7]
Groop L., Schalin C., Franssila-Kallunki A., Et al., Characteristics of non‐insulin‐dependent diabetic patients with secondary failure to oral antidiabetic therapy, Am j Med, 87, pp. 183-190, (1989)
[8]
DeFronzo RA, The triumvirate: β‐cell, muscle, liver. A collusion responsible for NIDDM, Diabetes, 37, pp. 667-687, (1988)
[9]
Janka HU, Standl E. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview, Diabete Metabol, 13, pp. 279-282, (1987)
[10]
Blackshear PJ, Roussel AM, Cohen AM, Nathan DM. Basal‐rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes. A prospective crossover trial, Diabetes Care, 12, pp. 455-463, (1989)